Dimension Inx

?? Dimension Inx is honored to be named a winner of the Up-and-Comer Award at this year’s 23rd annual Chicago Innovation Awards! ? “Our focus is always on the patient, developing advanced therapies that truly make a difference,” says our co-founder and CSO, Dr. Ramille S.. “Hyperelastic Bone? and CMFlex? are strides toward more accessible, effective bone repair solutions, and we’re thrilled to continue innovating within Chicago's dynamic and vibrant innovation ecosystem.” ? To learn more about CMFlex, visit: https://www.cmflex3d.com/ ? #Innovation #Healthcare #CMFlex #HyperelasticBone #ChicagoInnovation

?? Exciting News! ?? We've been selected as a Top 100 Finalist for the 2024 Chicago Innovation Awards! ?? This recognition is another testament to our incredible team's hard work, creativity, and dedication. They continue to push the boundaries of what’s possible. Thanks to everyone on our team for making this achievement possible.???Let’s go! ?? #AwardFinalist #ChicagoInnovation https://lnkd.in/gcbrkWU

?? From University of Illinois Chicago professor to startup success! Click below to learn more about how Dr. Ramille S. is transforming healthcare with groundbreaking 3D-printed biomaterials. As the Chief Scientific Officer of Dimension Inx, she’s leading the way in regenerative medicine, recently achieving FDA clearance for CMFlex?, a bone graft designed for facial reconstruction. Shah’s journey from academia to entrepreneurship proves that innovation and perseverance can change lives. We can’t wait to see what’s next! ?? #WomenInSTEM #Innovation #Entrepreneurship #BiomedicalEngineering https://lnkd.in/gpf5ndkj?

???Exciting News! We’ll be at the AAOMS Annual Meeting in Orlando, FL, from September 11th to 14th!??? ? ???Join us at Booth #406 to discover our innovative 3D-printed regenerative bone graft, CMFlex. Our unique macro and micro porosity design creates an environment that attracts?and promotes advanced cellular activity and vascularization, enhancing bone regeneration. ? Don’t miss the chance to explore this cutting-edge solution! We can’t wait to see you there! ? #DimensionInx #AAOMS #CMFlex #Innovation #BoneRegeneration

Exciting news! Dimension Inx was named a finalist at Fast Company 2024 Innovation by Design Awards for our pioneering work developing CMFlex?! CMFlex is a ready-to-use, flexible ceramic graft designed for bone reconstruction. It leverages a distinctive material microstructure and macroarchitecture for rapid vascularization and tissue integration to promote bone regeneration and remodeling, which can improve patient outcomes. To learn more about CMFlex, please visit https://www.cmflex3d.com/. We’re proud and honored to be recognized alongside others solving the problems of today and tomorrow. Check out the full list of the best designs from small businesses: https://lnkd.in/g5HYNxRp. #FCDesignAwards #RegenerativeMedicine #CMFlex #ChicagoInnovation

Thanks for the shout-out, Desktop Health! We're grateful for the continued partnership. We remain excited about this research program focused on using novel biomaterial scaffolds to drive follicular growth and maturation with our partners at Ann & Robert H. Lurie Children's Hospital of Chicago and Northwestern University, especially our collaborator, Monica M. Laronda. #Bioprinting #RegenerativeMedicine #3DBioplotter #Biomaterials #ArtificialOvary #WomensHealth

We’re excited to share that we’ve launched a new website for CMFlex, the first FDA-cleared fully synthetic 3D-printed regenerative bone graft. Our new website at?www.cmflex3d.com?provides detailed information about CMFlex's unique advantages, including its customizable fit, high porosity, and balanced flexibility and rigidity, designed for usability and to promote bone repair and regeneration. We’re proud to be paving the way for a new generation of advanced biomaterials and encourage you to check out the new website! #CMFlex #3dprinting #oralsurgery #dimensioninx #oralmaxillofacialsurgery #hydroxyapatite #bonegraft

We are excited to announce the recent issuance of Dimension Inx’s newest patent, US Patent No. 11,944,726, which covers the composition and manufacture of a novel, hydrogel-containing material family that is shelf-stable in its dry form, yet forms an interconnected gel network when hydrated, i.e., it’s “self-gelling”. ? This material family is unique because it enables the creation of 3D-printable, gel-laden, nanostructured implants and #injectables that combine the biofunctional nano- and #microstructure characteristics of our biomaterials with the additional biological benefits of hydrogels. It also offers an innovative and simple approach to the delivery, localization, and stabilization of one or more hydrogels in vivo. It’s yet another demonstration of our platform’s unique capabilities - simultaneous control of material architecture and composition to promote cell viability and tissue engraftment while maintaining manufacturability and user-friendliness. Thanks to our co-founder, Adam Jakus, Ph.D., who strategically developed this technology in response to existing limitations in the delivery and localization of hydrogel-based biomaterials. This work further expands upon an expansive patent portfolio at?Dimension Inx beyond implantable materials to include injectables – all of which are dedicated to the design and manufacture of advanced #biomaterials for #tissuetherapeutic products that rebuild healthy tissues and restore organ function. To learn more about our technology or if you're interested in joining a motivated team developing the next generation of regenerative therapeutics, please visit?https://lnkd.in/d5ttjxk8.

We are excited to announce the recent issuance of two patents, U.S. Patent No. 11,896,740, which covers the manufacture of our highly tunable and porous Fluffy-X? material family, and U.S. Patent No. 11,904,071, which covers the manufacture and use of our decellularized ECM-based Tissue Papers? material family. ? These material families highlight our platform’s unique capabilities - the control of both material structure and composition without compromising the ability to form complex constructs that demonstrate excellent handling properties and mechanical integrity. Our approach to the design and manufacture of advanced biomaterials for #tissuetherapeutic applications emphasizes the cellular and tissue microenvironment. We embrace the complex interplay between biology, material composition, microstructure, and macroarchitecture to direct optimal cell behavior and to create #regenerativemedicine products that rebuild healthy tissues and restore organ function. Shout out to our co-founders, Ramille S., Ph.D. and?Adam Jakus, Ph.D., who co-developed these technologies from nearly a decade of research at?Northwestern University’s Tissue Engineering and Additive Manufacturing Lab. We are continuing to expand upon their foundation and advance our patent portfolio at?Dimension Inx. To learn more about our technology or if you're interested in joining an motivated team developing the next generation of tissue therapeutics, please visit?https://lnkd.in/d5ttjxk8.

?? Exciting News! Last week Dimension Inx was awarded Honorable Mention at the 2023 3D Printing Industry Awards in the category of Medical, Dental, or Health Application. We are grateful for this recognition celebrating our first product, CMFlex?, being used in patients. This achievement marks a notable advancement for 3D-printed medical applications, and we are honored to be included among all the outstanding nominees. A big thank you ?? to our team for their relentless effort that continues to drive our success. ?? Also, a special congratulations to the category winner, Stratasys! #3dprinting #additivemanufacturing #healthcareinnovation https://lnkd.in/g9ZaEJdm